10-Q
Quarterly Report
Translational Development Acquisition Corp. TDAC TDACU TDACW
0001410578-25-001344
- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $206.6K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $438.17K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $322.9K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $210.3K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $6.36M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $6.25M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $415.42K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $650.23K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $176.6M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $175M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$507.66K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$507.66K |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $0 |
| Net Income | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Income | Q1 2025 · Mar 31, 2024 | $0 |